CARLOS
MACAYA MIGUEL
Profesor emérito
University Hospital of Bern
Berna, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Bern (11)
2020
-
Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial
Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 5, pp. E516-E526
2018
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
The Lancet, Vol. 392, Núm. 10151, pp. 940-949
2017
-
Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents
Journal of the American College of Cardiology, Vol. 70, Núm. 1, pp. 60-74
2016
-
The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes
EuroIntervention, Vol. 12, Núm. 1, pp. 79-87
2014
-
Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation
International Journal of Cardiology, Vol. 177, Núm. 2, pp. 448-454
2013
-
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: In-hospital results in 4,571 patients
EuroIntervention, Vol. 8, Núm. 12, pp. 1362-1371
2011
-
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial
JACC: Cardiovascular Interventions, Vol. 4, Núm. 4, pp. 432-441
2010
-
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
New England Journal of Medicine, Vol. 363, Núm. 2, pp. 136-146
2002
-
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial
Journal of the American Medical Association, Vol. 287, Núm. 24, pp. 3215-3222
1997
-
Die TREND-Studie (Trial on Reversing ENdothelial Dysfunction): ACE-Hemmung mit Quinapril verbessert die endotheliale vasomotorische Dysfunktion bei Patienten mit koronarer Herzerkrankung
Munchener Medizinische Wochenschrift, Vol. 139, Núm. 14, pp. 213-221